American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Becton Dickinson
BDX
|
+$389M |
| 2 |
Meta Platforms (Facebook)
META
|
+$296M |
| 3 |
Salesforce
CRM
|
+$207M |
| 4 |
Howmet Aerospace
HWM
|
+$122M |
| 5 |
Reinsurance Group of America
RGA
|
+$121M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$349M |
| 2 |
Visa
V
|
+$249M |
| 3 |
IQVIA
IQV
|
+$234M |
| 4 |
T-Mobile US
TMUS
|
+$226M |
| 5 |
NXP Semiconductors
NXPI
|
+$212M |
Sector Composition
| 1 | Technology | 23.35% |
| 2 | Healthcare | 13.84% |
| 3 | Financials | 13.36% |
| 4 | Consumer Discretionary | 11.5% |
| 5 | Industrials | 10.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2301
monday.com
MNDY
$9.82B
| $399K | ﹤0.01% |
+2,333
| New | +$399K |
|
|
HAYN
2302
DELISTED
Haynes International, Inc.
HAYN
| $399K | ﹤0.01% |
7,842
+2,739
| +54% | +$139K |
|
|
LX
2303
LexinFintech Holdings
LX
$983M
| $397K | ﹤0.01% |
173,525
-8,092
| -4% | -$18.5K |
|
2304
Protagonist Therapeutics
PTGX
$3.69B
| $396K | ﹤0.01% |
14,339
-1,278
| -8% | -$35.3K |
|
2305
FVCBankcorp
FVCB
$242M
| $395K | ﹤0.01% |
36,656
+397
| +1% | +$4.28K |
|
2306
Arcturus Therapeutics
ARCT
$489M
| $393K | ﹤0.01% |
+13,693
| New | +$393K |
|
|
ATRI
2307
DELISTED
Atrion Corp
ATRI
| $391K | ﹤0.01% |
692
+202
| +41% | +$114K |
|
|
HUYA
2308
Huya Inc
HUYA
$756M
| $390K | ﹤0.01% |
109,034
+1,825
| +2% | +$6.53K |
|
2309
Joby Aviation
JOBY
$12B
| $389K | ﹤0.01% |
37,902
+16,774
| +79% | +$172K |
|
2310
LSI Industries
LYTS
$679M
| $387K | ﹤0.01% |
30,786
+19,392
| +170% | +$244K |
|
2311
H.B. Fuller
FUL
$3.41B
| $386K | ﹤0.01% |
5,400
+491
| +10% | +$35.1K |
|
2312
MillerKnoll
MLKN
$1.43B
| $383K | ﹤0.01% |
25,942
+12,052
| +87% | +$178K |
|
2313
Acadia Pharmaceuticals
ACAD
$4.06B
| $383K | ﹤0.01% |
+16,004
| New | +$383K |
|
|
KAMN
2314
DELISTED
Kaman Corp
KAMN
| $382K | ﹤0.01% |
+15,715
| New | +$382K |
|
|
SP
2315
DELISTED
SP Plus Corporation
SP
| $380K | ﹤0.01% |
+9,720
| New | +$380K |
|
2316
STAAR Surgical
STAA
$1.39B
| $379K | ﹤0.01% |
7,210
-4,622
| -39% | -$243K |
|
2317
Kura Oncology
KURA
$746M
| $378K | ﹤0.01% |
35,729
+14,969
| +72% | +$158K |
|
2318
Select Water Solutions
WTTR
$956M
| $377K | ﹤0.01% |
46,578
+18,302
| +65% | +$148K |
|
2319
Conduent
CNDT
$458M
| $377K | ﹤0.01% |
110,894
+7,937
| +8% | +$27K |
|
2320
First Majestic Silver
AG
$5.05B
| $376K | ﹤0.01% |
66,500
| – | – |
|
2321
Entrada Therapeutics
TRDA
$198M
| $375K | ﹤0.01% |
+24,787
| New | +$375K |
|
|
CD
2322
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
| $370K | ﹤0.01% |
51,704
-2,267
| -4% | -$16.2K |
|
|
ACCD
2323
DELISTED
Accolade, Inc. Common Stock
ACCD
| $369K | ﹤0.01% |
27,416
+1,203
| +5% | +$16.2K |
|
2324
Thryv Holdings
THRY
$576M
| $369K | ﹤0.01% |
+15,005
| New | +$369K |
|
2325
Viper Energy
VNOM
$6.55B
| $368K | ﹤0.01% |
13,705
-364
| -3% | -$9.77K |
|